GuideCardiology
GARFIELD-AF risk tool (mortality, stroke and bleeding in atrial fibrillation)
GARFIELD-AF registry tool simultaneously estimating risk of death, stroke/systemic embolism and major bleeding up to 2 years in atrial fibrillation.
Updated 3 November 2026
When to use it
Patients with newly diagnosed atrial fibrillation, to compare expected outcomes with and without oral anticoagulation and support shared decision-making.
What it is
Model derived from the international prospective GARFIELD-AF registry (over 52,000 patients with newly diagnosed atrial fibrillation) and externally validated in ORBIT-AF and Danish registries. It integrates into one assessment the three outcomes that weigh on the anticoagulation decision.
Keep reading in the app
- Variables
- Performance
- Practical use
Practical tip
It discriminates better than CHA2DS2-VASc and HAS-BLED, including in patients at low risk by those scores.
2 more practical tips in the app.
Reference
- Fox KAA, Lucas JE, Pieper KS, et al. Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation. BMJ Open. 2017;7(12):e017157.
- Fox KAA, Virdone S, Pieper KS, et al. GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation. Eur Heart J Qual Care Clin Outcomes. 2022;8(2):214-227.
Official source: Official GARFIELD-AF calculator
A support tool for healthcare professionals: it guides and does not replace clinical judgement.
